Cowie Robin Harper's Form 4 filing
Biodesix Inc (BDSX) · filed Feb 23, 2026
- Accession no.
- 0000905148-26-000989
- Filed
- Feb 23, 2026
- Trade date
- Feb 20-23, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.84K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cowie Robin HarperCIK 0001827690 | Officer (CFO, Sec'y & Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Common Stock | MOption exerciseAcquired | +1,469 | – | – | 16,766 | Direct | |
| Feb 23, 2026 | Common Stock | SSaleDisposed | −535 | $12.78 | −$6,837.3 | 16,231 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Common Stock | MOption exerciseDisposed | −1,469 | $0.00 | $0 | 4,406 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.